US 12,329,720 B2
Dosing systems and approaches
Chia-Jung Wu, Redondo Beach, CA (US); Nicholas J. Clark, Thousand Oaks, CA (US); Ronak Maheshwari, Thousand Oaks, CA (US); and Heather N. Franey, Ventura, CA (US)
Assigned to AMGEN INC., Thousand Oaks, CA (US)
Filed by AMGEN INC., Thousand Oaks, CA (US)
Filed on Feb. 5, 2020, as Appl. No. 16/782,306.
Claims priority of provisional application 62/804,447, filed on Feb. 12, 2019.
Prior Publication US 2020/0253823 A1, Aug. 13, 2020
Int. Cl. A61J 1/10 (2006.01); A61J 1/14 (2023.01); A61J 1/16 (2023.01); A61M 5/148 (2006.01)
CPC A61J 1/10 (2013.01) [A61J 1/1487 (2015.05); A61J 1/16 (2013.01); A61M 5/148 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A drug delivery system comprising:
a delivery container including an upper portion, a lower portion, a first side portion, a second side portion, and a tapered region extending between the first side portion and the second side portion, the delivery container further including an interior cavity, the tapered region including a surface area between seams defining the interior cavity;
a first drug insertion port positioned at the lower portion of the delivery container through the surface area of the tapered region, the first drug insertion port having a luer lock;
at least one additional drug insertion port positioned at the lower portion of the delivery container through the surface area of the tapered region, the at least one additional drug insertion port not having a luer lock; and
an IV connection port positioned at the lower portion of the delivery container adjacent to a lower portion of the tapered region, wherein the surface area is downwardly angled from the first side portion toward the IV connection port.